valproic acid has been researched along with losartan potassium in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Akpolat, T; Caglar, S; Sungur, A; Sungur, C; Turgan, C; Yasavul, U | 1 |
| Blau, CA; Dover, G; Fournarakis, B; Josephson, B; Li, Q; Liakopoulou, E; Papayannopoulou, T; Raisys, V; Stamatoyannopoulos, G; Wolf, JA | 1 |
| Farooq, MU; Gupta, R; Kassab, M; Majid, A; Reeves, M; Zemke, D | 1 |
| Heike, Y; Ino, K; Katayama, N; Liu, B; Masuya, M; Monma, F; Nishii, K; Ohishi, K; Sekine, T; Suzuki, K; Takaue, Y; Yamamura, K | 1 |
| Biermann, J; Boyle, J; Lagrèze, WA; Pielen, A | 1 |
| Fernandez, L; Gurevich, M; Hurst, LC; Komatsu, DE | 1 |
| Basiri, M; Darvishzadeh-Mahani, F; Haratizadeh, S; Nozari, M; Ranjbar, M | 1 |
1 review(s) available for valproic acid and losartan potassium
| Article | Year |
|---|---|
Emerging Strategies on Adjuvant Therapies for Nerve Recovery.
Topics: Absorbable Implants; Allografts; Autografts; Calcium Channel Blockers; Erythropoietin; Gabapentin; Humans; Immunosuppressive Agents; Lithium Compounds; Nerve Regeneration; Neuroprotective Agents; Neurosurgical Procedures; Peripheral Nerve Injuries; Peripheral Nerves; Recovery of Function; Riluzole; Stem Cell Transplantation; Valproic Acid; Veins; Wallerian Degeneration | 2018 |
6 other study(ies) available for valproic acid and losartan potassium
| Article | Year |
|---|---|
Unresponsiveness to human recombinant erythropoietin in an epileptic dialysis patient secondary to valproic acid toxicity.
Topics: Adult; Electrocardiography; Epilepsy, Tonic-Clonic; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Phenytoin; Recombinant Proteins; Renal Dialysis; Valproic Acid | 1992 |
Stimulation of fetal hemoglobin production by short chain fatty acids.
Topics: Adult; Anemia, Sickle Cell; Animals; Anticonvulsants; Butyrates; Butyric Acid; Cells, Cultured; Epilepsy; Erythroid Precursor Cells; Erythropoietin; Fatty Acids, Volatile; Fetal Hemoglobin; Gene Expression Regulation; Globins; Hemoglobinopathies; Humans; Papio; Pentanoic Acids; Propionates; Reticulocytes; RNA, Messenger; Structure-Activity Relationship; Valproic Acid | 1995 |
The effect of anticonvulsant drugs on the fibrinolytic activity of tissue plasminogen activator.
Topics: Adult; Anticonvulsants; Blood Coagulation; Drug Interactions; Erythropoietin; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Levetiracetam; Male; Phenobarbital; Phenytoin; Piracetam; Recombinant Proteins; Tissue Plasminogen Activator; Valproic Acid | 2008 |
A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis.
Topics: Antigens, CD34; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; GABA Agents; GATA1 Transcription Factor; GATA2 Transcription Factor; Gene Expression Regulation; Humans; Integrin beta3; Interleukin-3; Megakaryocytes; Myelodysplastic Syndromes; RNA, Messenger; Stem Cells; Thrombopoiesis; Thrombopoietin; Valproic Acid | 2010 |
Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells.
Topics: Animals; Animals, Newborn; Cell Death; Densitometry; Epigenesis, Genetic; Erythropoietin; Histone Deacetylase Inhibitors; Hydroxamic Acids; Isobutyrates; Microscopy, Phase-Contrast; Rats; Retina; Retinal Ganglion Cells; Valproic Acid | 2011 |
The effects of postnatal erythropoietin and nano-erythropoietin on behavioral alterations by mediating K-Cl co-transporter 2 in the valproic acid-induced rat model of autism.
Topics: Animals; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Erythropoietin; Female; gamma-Aminobutyric Acid; Hippocampus; Humans; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Symporters; Valproic Acid | 2023 |